Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Molecular Cancer Therapeutics|March 17, 2007
Targeting BRAFV600E in thyroid carcinoma: therapeutic implicationsConstantine S Mitsiades, Joseph Negri, Ciaran McMullan, et al.
Investigative Ophthalmology & Visual Science|December 30, 2004
Human retinoblastoma cells are resistant to apoptosis induced by death receptors: role of caspase-8 gene silencingVassiliki Poulaki, Constantine S Mitsiades, Ciaran McMullan, et al.
Molecular Neurodegeneration|September 21, 2022
Elevated ganglioside GM2 activator (GM2A) in human brain tissue reduces neurite integrity and spontaneous neuronal activityYi-Chen Hsieh, Joseph Negri, Amy He, et al.
ACS Medicinal Chemistry Letters|March 13, 2012
Discovery of 1,3-Diaminobenzenes as Selective Inhibitors of Platelet Activation at the PAR1 ReceptorChris Dockendorff, Omozuanvbo Aisiku, Lynn Verplank, et al.
Plos One|July 14, 2011
Microenvironmental influence on pre-clinical activity of polo-like kinase inhibition in multiple myeloma: implications for clinical translationDouglas W McMillin, Jake Delmore, Joseph Negri, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 25, 2019
Cell models of lipid-rich α-synuclein aggregation validate known modifiers of α-synuclein biology and identify stearoyl-CoA desaturaseThibaut Imberdis, Joseph Negri, Nagendran Ramalingam, et al.
Plos One|March 27, 2015
Modulators of hepatic lipoprotein metabolism identified in a search for small-molecule inducers of tribbles pseudokinase 1 expressionMarek M Nagiec, Adam P Skepner, Joseph Negri, et al.
Cancer Research|July 9, 2009
Antimyeloma activity of the orally bioavailable dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor NVP-BEZ235Douglas W McMillin, Melissa Ooi, Jake Delmore, et al.
British Journal of Haematology|January 13, 2011
Molecular and cellular effects of multi-targeted cyclin-dependent kinase inhibition in myeloma: biological and clinical implicationsDouglas W McMillin, Jake Delmore, Joseph Negri, et al.
Medchemcomm|December 14, 2018
Novel tricyclic glycal-based TRIB1 inducers that reprogram LDL metabolism in hepatic cellsMarek M Nagiec, Jeremy R Duvall, Adam P Skepner, et al.
Pageof 3